|
|
|
|
|
|
|
|
|
|
Rv1908c More about Rv1908c on TBDB.org More about Rv1908c on TubercuList |
Display all mutations or select a bar from the histogram above to examine in greater detail |
| Rv1908c: Codons 180 to 199: 8 mutations (high confidence mutations are highlighted in yellow) | |||||||||||||||
| Primary reference | Polymorphism | Nucleotide position | Codon position | Amino acid | Time period | Origin | Molecular detection method | Gene coverage | Resistance pattern | MIC | Susceptibility testing method | R/Total isolates | R/S isolates with mutation | Additional mutations | High confidence support |
| Secondary Publication: Hazbon MH AAC 2006 | ACG/AAG | 539 | 180 | Thr/Lys | - | - | - | - | - | - | - | - | - | - | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | ACG/??? | See Note | 180 | Thr/Cys | - | - | - | - | - | - | - | - | - | - | - |
| Chan RCY JAC 2007 | GGC/GTC | 557 | 186 | Gly/Val | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | Whole gene | N.S. | - | Absolute concentration method | 250 | 241 | 1 | - |
| Chan RCY JAC 2007 | GGC/CAC | 556-557 | 186 | Gly/His | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | Whole gene | N.S. | - | Absolute concentration method | 250 | 241 | 1 | - |
| Baker LV AAC 2005 | TGG/CGG | 571 | 191 | Trp/Arg | 1998 | United Kingdom | Directed Oligonucleotide array, Sequencing | Whole gene | H,HS,HE,HSE,MDR | ratio>=4 | Resistance ratio method | 202/378 | 1/0 | - | - |
| Chan RCY JAC 2007 | del G | 572 | 191 | Frameshift | 1994-2004 | Hong Kong | PCR-SSCP, Sequencing | Whole gene | N.S. | - | Absolute concentration method | 250 | 241 | 1 | - |
| Morlock GP AAC 2003 | G/A | 583 | 195 | Glu/Lys | 2003 | USA | Sequencing | Whole gene | Eth | 1 | Microplate alamar blue assay | 17/41 | 0/1 | nt 280 T/G inh ORF | - |
| Secondary Publication: Ramaswamy S Musser JM Tubercle lung Dis 1998 | TGG/TGA | 594 | 198 | Trp/STOP | - | - | - | - | - | - | - | - | - | - | - |
Disclaimer: These are all putative mutations found in drug resistant clinical TB isolates. No a priori decisions have been made as to whether these mutations are causally related to resistance or possible secondary mutations. |
|
© 2010 Andreas Sandgren | Supported by the Swedish Research Council | Contact Database Curator |